Robin L. Goodwin, C-FNP
Nurse Practitioners (Family Nurse Practitioner)
- Medicare participating
At a glance
- Years since graduation
- 16
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 216
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Nurse Practitioner primary
WV license 2011001807
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- West Virginia University Hospitals, Inc Morgantown, WV
- Preston Memorial Hospital Kingwood, WV
Medical groups
- Preston Health Care Services LLC (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 216
- Services billed
- 2,957
- Patients’ average age
- 67
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 464 | 203 |
| Insertion of needle into vein for collection of blood sample | 116 | 85 |
| Injection of drug or substance under skin or into muscle | 83 | 35 |
| Injection, ketorolac tromethamine, per 15 mg | 68 | 15 |
| Urinalysis, manual test | 31 | 27 |
| New patient office or other outpatient visit, 30-44 minutes | 26 | 26 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 23 | 19 |
| X-ray of chest, 2 views | 17 | 14 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 17 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 29 payments worth $503 in total to this clinician.
| AbbVie Inc. | $209 |
|---|---|
| Abbott Laboratories | $163 |
| Millicent US Inc | $63.24 |
| Viatris Specialty LLC | $19.65 |
| Vertex Pharmaceuticals Incorporated | $16.51 |
| Pfizer Inc. | $16.07 |
| AstraZeneca Pharmaceuticals LP | $15.89 |
| Food and Beverage | $503 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $1,545 in research payments for these studies, mostly to the institutions running them.
- Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine
AbbVie Inc. · Completed · NCT05216263
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.